Phasic craving for carbohydrate observed with citalopram

International Clinical Psychopharmacology

Volumn 11, Issue 4, 1996, Pages 273-278

  Bouwer, C D ^a   Harvey, B H ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

carbohydrate craving; citalopram; dopamine; histamine; SSRI; weight gain

Indexed keywords

CARBOHYDRATE; CITALOPRAM; FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; DEPRESSION; FEMALE; HUMAN; MALE; NAUSEA; PATIENT COMPLIANCE; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; WEIGHT GAIN;

EID: 0030452295     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199612000-00009     Document Type: Article

References (31)

1. Arya DK (1994) Extrapyramidal symptoms with selective serotonin re-uptake inhibitors. British Journal of Psychiatry, 165, 728-733.
2. Beaumont G, Kasper S, O'Hanlon J and Mendlewicz J (1995) Antidepressant side effects and adverse reactions. Depression, 2, 138-144.
3. Blundell JE (1990) Appetite disturbances and the problems of overweight. Drugs, 39 (suppl 3), 1-19.
4. Finley PR (1994) Selective serotonin reuptake inhibitors: pharmacological profiles and potential therapeutic distinctions. Annals of Pharmacotherapy, 28, 1359-1369.
5. Goldbloom DS, Garfinkel PE and Shaw BF (1991) Biochemical aspects of bulimia nervosa. Journal of Psychosomatic Research, 35 (suppl 1), 11-22.
6. Goldstein DJ, Rampey AH, Enas GG, Potvin JH, Fludzinski LA and Levine LR (1994) Fluoxetine: a randomized clinical trial in the treatment of obesity. International Journal of Obesity, 18, 129-135.
7. Goodwin GM (1996) How do antidepressants affect serotonin receptors? The role of serotonin receptors in the therapeutic and side effect profile of the SSRIs. Journal of Clinical Psychiatry, 57 (suppl 4), 9-13.
8. Hyman SE and Nestler EJ (1996) Initiation and adaptation: a paradigm for understanding psychotropic drug action. American Journal of Psychiatry, 153, 151-162.
9. Hyttel J (1994) Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). International Clinical Psychopharmacology, 9 (suppl 1), 19-26.
10. Ichikawa J and Meltzer HY (1995) Effect of antidepressants on striatal and accumbens extracellular dopamine levels. European Journal of Pharmacology, 281, 255-261.
11. Kasper S and Heiden A (1995) Do SSRIs differ in their antidepressant efficacy? Human Psychopharmacology, 10 (suppl 3), S163-S172.
12. Kasper S, Lepine JP, Mendlewicz J, Montgomery SA and Rush AJ (1995) Efficacy, safety and indications for tricyclic and newer antidepressants. Depression, 2, 127-137.
13. Lambert PD, Wilding JP, Al-Dokhayel AA, Bohuon C, Comoy E, Gilbey SG and Bloom SR (1993) A role for neuropeptide Y, dynorphin and noradrenaline in the central control of food intake after food deprivation. Endocrinology, 133, 29-32.
14. Leibowitz SF (1990) The role of serotonin in eating disorders. Drugs, 35 (suppl 3), 33-48.
15. Leonard BE (1995) SSRI differentiation: pharmacology and pharmacokinetics. Human Psychopharmacology, 10 (suppl 3), S149-S158.
16. Marek GJ, McDougle CJ, Price LH and Seiden LS (1992) A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant action. Psychopharmacology (Berlin), 109, 2-11.
17. McEvoy GK (Ed.) (1991) American Hospital Formulary Service, pp.2-30. American Society of Hospital Pharmacists, Bethesda, MD.
18. Mercer LP, Kelley DS, Humphries LL and Dunn JD (1994) Manipulation of central nervous system histamine or histaminergic receptors (H1) affects food intake in rats Journal of Nutrition, 124, 1029-1036.
19. Phelix CF and Broderick PA (1995) Light microscopic immunocytochemical evidence of converging serotonin and dopamine terminals in ventrolateral nucleus accumbens. Brain Research Bulletin, 37, 37-40.
20. Physicians Desk Reference (1996) Medical Economics Data. Montvale, NJ.
21. Preskon SH (1995) Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline and venlafaxine. Journal of Clinical Psychiatry, 56 (suppl 6), 12-21.
22. Richelson E (1994) The pharmacology of antidepressants at the synapse: focus on newer compounds. Journal of Clinical Psychiatry, 55 (suppl A), 34-39.
23. Richelson E and Nelson A (1984) Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro. Journal of Pharmacology and Experimental Therapeutics, 230, 94-102.
24. Sakata T, Fukagawa K, Ookuma K, Fujimoto K, Yoshimatsu H, Yamatodani A and Wada H (1990) Hypothalamic neuronal histamine modulation of ad libitum feeding by rats. Brain Research, 537, 303-306.
25. Sanders-Bush GK and Mayer SE (1996) 5-Hydroxtryptamine (serotonin) receptor agonists and antagonists. In: The Pharmacological Basis of Therapeutics, 9th edn (Eds J Hardman and LE Limbird), pp.249-263. McGraw-Hill, New York.
26. Sternbach H (1991) The serotonin syndrome. American Journal of Psychiatry, 148, 705-713.
27. Szkudlarek J and Elsborg L (1993) Treatment of severe obesity with a highly selective serotonin reuptake inhibitor as a supplement to a low calorie diet. International Journal of Obesity and Related Metabolic Disorders, 17, 681-683.
28. Tuomisto L (1994) Regulation of feeding behaviour, with special reference to histamine. Journal of Physiological Pharmacology, 45, 469-477.
29. Weisler RH, Johnston JA, Lineberry CG, Samara B, Branconnier RJ and Billow AA (1994) Comparison of bupropion and trazodone for the treatment of major depression. Journal of Clinical Psychopharmacology, 14, 170-179.
30. Wise SD (1992) Clinical studies with fluoxetine in obesity. American Journal of Clinical Nutrition, 55 (suppl), 181S-184S.
31. Wong DT, Threlkeld PG and Robertson DW (1991) Affinities of fluoxetine, its enantiomers and other inhibitors of serotonin uptake inhibitors for subtypes of serotonin receptors. Neuropsychopharmacology, 5, 43-47.